Encephalocraniocutaneous lipomatosis: genes and variants
Explore variant evidence for Encephalocraniocutaneous lipomatosis across 2 analyzed proteins (FGFR1, KRAS). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 14 variants of uncertain significance and 12 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Encephalocraniocutaneous lipomatosis
FGFR1: Fibroblast growth factor receptor 1
Its fibroblast-growth-factor signaling controls proliferation, differentiation, migration, and developmental patterning in many tissues. Germline pathogenic variants can cause hypogonadotropic hypogonadism or craniosynostosis syndromes, while fusions and other activating alterations drive selected cancers.
3 ClinVar pathogenic / likely pathogenic and 26 uncertain variants in FGFR1 have source records linked to Encephalocraniocutaneous lipomatosis. Association strength is not clinical gene validity.
KRAS: GTPase KRas
A small GTPase that acts as a molecular switch in the RAS-MAPK signaling pathway. By cycling between GDP- and GTP-bound states, it relays growth and survival signals, and activating KRAS variants are common drivers of cancer.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KRAS have source records linked to Encephalocraniocutaneous lipomatosis. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Encephalocraniocutaneous lipomatosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| KRAS A146P | 146 | Pathogenic / likely pathogenic (★★) | |
| KRAS A146T | 146 | Pathogenic / likely pathogenic (★★) | |
| FGFR1 G237D | 237 | Ig-like C2-type 2 | Pathogenic / likely pathogenic (★★) |
| FGFR1 N546K | 546 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR1 K656E | 656 | Protein kinase | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Hypogonadotropic hypogonadism 2 with or without anosmia also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Encephalocraniocutaneous lipomatosis variants (55 pathogenic / likely pathogenic).
- Pfeiffer syndrome also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Encephalocraniocutaneous lipomatosis variants (18 pathogenic / likely pathogenic).
- Hartsfield-Bixler-Demyer syndrome also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Encephalocraniocutaneous lipomatosis variants (13 pathogenic / likely pathogenic).
- Jackson-Weiss syndrome also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Encephalocraniocutaneous lipomatosis variants (5 pathogenic / likely pathogenic).
- Osteoglophonic dysplasia also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Encephalocraniocutaneous lipomatosis variants (5 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Encephalocraniocutaneous lipomatosis variants (23 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Encephalocraniocutaneous lipomatosis variants (16 pathogenic / likely pathogenic).
- Cardiofaciocutaneous syndrome also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Encephalocraniocutaneous lipomatosis variants (9 pathogenic / likely pathogenic).
- Autoimmune lymphoproliferative syndrome also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Encephalocraniocutaneous lipomatosis variants (5 pathogenic / likely pathogenic).
- Non-small cell lung carcinoma also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Encephalocraniocutaneous lipomatosis variants (5 pathogenic / likely pathogenic).
Diseases related to Encephalocraniocutaneous lipomatosis
- Colorectal cancer, also linked to FGFR1 and KRAS
- Non-small cell lung carcinoma, also linked to FGFR1 and KRAS
- RASopathy, also linked to KRAS
- Noonan syndrome, also linked to KRAS
- Noonan syndrome and Noonan-related syndrome, also linked to KRAS
- Hypogonadotropic hypogonadism 2 with or without anosmia, also linked to FGFR1
- Cardiofaciocutaneous syndrome, also linked to KRAS
- Cardio-facio-cutaneous syndrome, also linked to KRAS
- Acute myeloid leukemia, also linked to KRAS
- Pfeiffer syndrome, also linked to FGFR1
- Autoimmune lymphoproliferative syndrome, also linked to KRAS
- Hereditary breast cancer, also linked to KRAS
Frequently asked questions
Which genes have records linked to Encephalocraniocutaneous lipomatosis?
This view contains 2 analyzed proteins: FGFR1, KRAS. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 14 variants of uncertain significance and 12 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 32 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center